The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy

AbstractBackground The application of podocyte antigen M-type phospholipase A2 receptor (PLA2R, GAg) and serum anti-PLA2R antibody (SAb) in predicting the prognosis of membrane nephropathy (MN) was controversial.Method 328 biopsy-proven MN patients were divided into three phenotypes, 182 MN patients...

Full description

Bibliographic Details
Main Authors: Yang Chen, Ying Xu, Siyu Chen, Yedong Yu, Xueling Zhu, Jianghua Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Membranous nephropathy
PLA2R
anti-PLA2R
diagnosis
prognosis
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2264939

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2023.2264939

Similar Items